Exploring the potential of anticancer peptides as therapeutic agents for cancer treatment.
Anticancer peptides show promise in targeting tumors with low toxicity. Key findings from PubMed article reviewed. 🧬💊
May 30, 2025
Follow us
latest articles
Discover the newest research about AI innovations in 💊 Pharmacy.
Coreline Soft Secures AI Imaging Contracts with NHS and Boehringer Ingelheim
Coreline Soft secures AI imaging contracts with NHS and Boehringer Ingelheim, enhancing medical image analysis in healthcare. 🏥📊
May 30, 2025
Enhancing search strategies for systematic reviews on drug Harms: An evaluation of the utility of ChatGPT in error detection and keyword generation.
ChatGPT enhances drug harm reviews: 49% keyword recreation, 0.17 Jaccard similarity. Effective error detection tool! 📊💊
May 30, 2025
Evaluation of Diagnostic Recommendations Embedded in Medication Alerts: Prospective Single-Arm Interventional Study.
Evaluating machine learning in outpatient care: 2.28% alert rate, 56.55% acceptance. Key findings on diagnostic recommendations. 📊💊
May 28, 2025
New Prescription Tracking Feature Launched in NHS App
NHS App introduces prescription tracking feature 📱💊, allowing real-time updates to reduce pharmacy visits and calls.
May 24, 2025
Serve You Rx Partners with Amazon Pharmacy for Home Delivery Services
Serve You Rx partners with Amazon Pharmacy for home delivery of maintenance medications. Members gain 24/7 pharmacist access and transparent pricing. 📦💊
May 3, 2025
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
Patient experiences with intranasal esketamine show 88.4% report improved quality of life in treatment-resistant depression. 🌟🧠
April 26, 2025
Eli Lilly Takes Legal Action Against Telehealth Companies for Selling Unapproved Drugs
Eli Lilly has filed lawsuits against telehealth companies for selling unapproved drugs containing tirzepatide, risking patient safety. ⚖️💊
April 26, 2025
Mark Cuban Cost Plus Drug Company Collaborates with Morris & Dickson for Medication Access
Mark Cuban Cost Plus Drug Company partners with Morris & Dickson to enhance access to essential injectable medications. 💊🤝
April 17, 2025
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics.
Pharmacogenomics enhances drug therapy for rare diseases, optimizing treatment and minimizing adverse reactions. AI tools play a crucial role. 🧬💊
April 9, 2025